Effectiveness of Identifying C. difficile Asymptomatic Carriers on the Incidence of C. difficile Infection (EFFICACI): A Stepped Wedge Cluster Randomized Trial

识别艰难梭菌无症状携带者对艰难梭菌感染发生率的有效性 (EFFICACI)：阶梯式楔形集群随机试验

• 批准号: 432968
• 负责人: Longtin Yves
• 金额: $ 7.29万
• 依托单位: Lady Davis Institute for Medical Research (Mtl)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-04-01 至 2021-04-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=432968&lang=en
• 关键词: Antibimicrobial Stewardship; Asymptomatic Carriage; Clostridium Difficile Infection; Infection Prevention And Control; Interventional Study; Isolation Precautions; Population-Based Research; Stepped Wedge Cluster Randomized Trial

C. difficile infection (CDI) is a burdensome diarrheal disease that causes 38,000 cases and 2,000 deaths each year in Canada. While treatment exists, cure is not guaranteed. There is an important need to discover new strategies to protect Canadians from C

C.艰难梭菌感染（CDI）是一种负担沉重的肠道疾病，在加拿大每年造成38，000例病例和2，000例死亡。虽然有治疗方法，但不能保证治愈。有一个重要的需要，以发现新的战略，以保护加拿大人从C